Upregulation of major histocompatibility complex class II, CD83, CD64, and CD14 on polymorphonuclear neutrophils stimulated with interleukin-15

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 6, 2008, Pages 462-468

  Abdel Salam, Bahaa Kenawy Abuel Hussien ^a   Ebaid, Hossam ^a  

^a Minia University ^*  (Egypt)

Author keywords

Antigens, CD; Interleukin 15; Major histocompatibility complex; Neutrophils; Receptors, IgG

Indexed keywords

CARBON DIOXIDE; CD14 ANTIGEN; CD64 ANTIGEN; CD83 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 15; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOFLUOROMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULE; NEUTROPHIL; NORMAL HUMAN; UPREGULATION;

ANTIGENS, CD; ANTIGENS, CD14; FLOW CYTOMETRY; GENES, MHC CLASS II; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-15; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; RECEPTORS, IGG; UP-REGULATION;

EID: 62149127368     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Weber RL, Iacono VJ. The cytokines: a review of interleukins. Periodontal Clin Investig. 1997;19:17-22.
2. Balkwill FR, Burke F. The cytokine network. Immunol Today. 1989;10:299-304.
3. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996;17:138-46.
4. Bhandari V. Developmental differences in the role of interleukins in hyperoxic lung injury in animal models. Front Biosci. 2002;7:d1624-33.
5. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D. IL-15, a novel T-cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol. 1995;57:763-6.
6. Girard D, Boiani N, Beaulieu AD. Human neutrophils express the interleukin-15 receptor alpha chain (IL-15Ralpha) but not the IL-9Ralpha component. Clin Immunol Immunopathol. 1998;88:232-40.
7. Nishimura H, Yajima T, Naiki Y, Tsunobuchi H, Umemura M, Itano K, et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med. 2000;191:157-70.
8. Cassatella MA, McDonald PP. Interleukin-15 and its impact on neutrophil function. Curr Opin Hematol. 2000;7:174-7.
9. Girard D, Paquet ME, Paquin R, Beaulieu AD. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood. 1996;88:3176-84.
10. McDonald PP, Russo MP, Ferrini S, Cassatella MA. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils. Blood. 1998;92:4828-35.
11. Musso T, Calosso L, Zucca M, Millesimo M, Puliti M, Bulfone-Paus S, et al. Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells. Infect Immun. 1998;66:2640-7.
12. Mastroianni CM, d'Ettorre G, Forcina G, Lichtner M, Mengoni F, D'Agostino C, et al. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. Blood. 2000;96:1979-84.
13. Zissel G, Bäumer I, Schlaak M, Müller-Quernheim J. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases. Eur Cytokine Netw. 2000;11:105-12.
14. Muro S, Taha R, Tsicopoulos A, Olivenstein R, Tonnel AB, Christodoulopoulos P, et al. Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol. 2001;108:970-5.
15. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today. 1995;16:21-6.
16. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today. 1992;13:169-72.
17. Wei S, Liu JH, Blanchard DK, Djeu JY. Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J Immunol. 1994;152:3630-6.
18. Newburger PE, Subrahmanyam YV, Weissman SM. Global analysis of neutrophil gene expression. Curr Opin Hematol. 2000;7:16-20.
19. Radsak M, Iking-Konert C, Stegmaier S, Andrassy K, Hänsch GM. Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation. Immunology. 2000;101:521-30.
20. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol. 1993;151:1482-90.
21. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. CD14 is a pattern recognition receptor. Immunity. 1994;1:509-16.
22. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA. 1993;90:2380-4.
23. Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA. 1993;90:2744-8.
24. Wright SD. CD14 and innate recognition of bacteria. J Immunol. 1995;155:6-8.
25. Haziot A, Ferrero E, Köntgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity. 1996;4:407-14.
26. Perera PY, Vogel SN, Detore GR, Haziot A, Goyert SM. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J Immunol. 1997;158:4422-9.
27. Schimke J, Mathison J, Morgiewicz J, Ulevitch RJ. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc Natl Acad Sci USA. 1998;95:13875-80.
28. Verbon A, Dekkers PE, ten Hove T, Hack CE, Pribble JP, Turner T, et al. IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol. 2001;166:3599-605.
29. Wagner C, Deppisch R, Denefleh B, Hug F, Andrassy K, Hänsch GM. Expression patterns of the lipopolysaccharide receptor CD14, and the FCgamma receptors CD16 and CD64 on polymorphonuclear neutrophils: data from patients with severe bacterial infections and lipopolysaccharide-exposed cells. Shock. 2003;19:5-12.
30. Zhou LJ, Schwarting R, Smith HM, Tedder TF. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol. 1992;149:735-42.
31. Fujimoto Y, Tu L, Miller AS, Bock C, Fujimoto M, Doyle C, et al. CD83 expression influences CD4+ T cell development in the thymus. Cell. 2002;108:755-67.
32. Pickl WF, Majdic O, Kohl P, Stöckl J, Riedl E, Scheinecker C, et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol. 1996;157:3850-9.
33. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA. 1996;93:2588-92.
34. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol. 1998;160:4587-95.
35. Oehler L, Majdic O, Pickl WF, Stöckl J, Riedl E, Drach J, et al. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med. 1998;187:1019-28.
36. Yamashiro S, Wang JM, Yang D, Gong WH, Kamohara H, Yoshimura T. Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood. 2000;96:3958-63.
37. Iking-Konert C, Csekö C, Wagner C, Stegmaier S, Andrassy K, Hänsch GM. Transdifferentiation of polymorphonuclear neutrophils: acquisition of CD83 and other functional characteristics of dendritic cells. J Mol Med. 2001;79:464-74.
38. Lechmann M, Krooshoop DJ, Dudziak D, Kremmer E, Kuhnt C, Figdor CG, et al. The extracellular domain of CD83 inhibits cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med. 2001;194:1813-21.
39. Scholler N, Hayden-Ledbetter M, Dahlin A, Hellström I, Hellström KE, Ledbetter JA. Cutting edge: CD83 regulates the development of cellular immunity. J Immunol. 2002;168:2599-602.